These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29194488)

  • 1. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    Kontoyiannis DP; Selleslag D; Mullane K; Cornely OA; Hope W; Lortholary O; Croos-Dabrera R; Lademacher C; Engelhardt M; Patterson TF
    J Antimicrob Chemother; 2018 Mar; 73(3):757-763. PubMed ID: 29194488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Desai AV; Kovanda LL; Hope WW; Andes D; Mouton JW; Kowalski DL; Townsend RW; Mujais S; Bonate PL
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
    Bogler Y; Stern A; Su Y; Lee YJ; Seo SK; Shaffer B; Perales MA; Papanicolaou GA; Neofytos D
    Med Mycol; 2021 Oct; 59(10):970-979. PubMed ID: 34036319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and budgetary impact evaluation of isavuconazole (Cresemba®) versus voriconazole (Vfend®) for the treatment of patients with possible invasive aspergillosis from the perspective of the Brazilian supplementary health system.
    Araujo GLV; Murta Amaral L; Ponzio V; Rocha JL
    PLoS One; 2024; 19(3):e0299056. PubMed ID: 38427635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis: a network meta-analysis.
    Liu A; Xiong L; Wang L; Zhuang H; Gan X; Zou M; Wang X
    BMC Infect Dis; 2024 Jun; 24(1):581. PubMed ID: 38867163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
    Monzó-Gallo P; Lopera C; Badía-Tejero AM; Machado M; García-Rodríguez J; Vidal-Cortés P; Merino E; Calderón J; Fortún J; Palacios-Baena ZR; Pemán J; Sanchis JR; Aguilar-Guisado M; Gudiol C; Ramos JC; Sánchez-Romero I; Martin-Davila P; López-Cortés LE; Salavert M; Ruiz-Camps I; Chumbita M; Aiello TF; Peyrony O; Puerta-Alcalde P; Soriano A; Marco F; Garcia-Vidal C
    Int J Infect Dis; 2024 Jul; 144():107070. PubMed ID: 38663477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
    Henao-Martínez AF; Chastain DB; Thompson GR
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0072123. PubMed ID: 37671871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients.
    Silva JT; Husain S; Aguado JM
    Transpl Int; 2023; 36():11845. PubMed ID: 38161768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?
    Bienvenu AL; Leray V; Guichon C; Bourget S; Chapuis C; Duréault A; Pavese P; Roux S; Kahale E; Chaabane W; Subtil F; Maucort-Boulch D; Talbot F; Dode X; Ghesquières H; Leboucher G
    Ann Pharm Fr; 2024 May; 82(3):514-521. PubMed ID: 38000506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications.
    Raad II; Chaftari AM; Al Shuaibi MM; Jiang Y; Shomali W; Cortes JE; Lichtiger B; Hachem RY
    Ann Oncol; 2013 Jul; 24(7):1873-1879. PubMed ID: 23519997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of isavuconazole antifungal medicine to treat mold infections in Asia and the Western Pacific region: a plain language summary.
    Pfaller MA; Carvalhaes CG; Rhomberg PR; Castanheira M
    Future Microbiol; 2024 Feb; 19():173-180. PubMed ID: 38018423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial.
    Yu X; Xu L; Zheng J; Lei Z; Pang Y; Li X; Zhu J; Liu J
    Trials; 2023 Dec; 24(1):811. PubMed ID: 38105213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Study of Cerebral Aspergillosis treated with Isavuconazole: an EFISG study.
    Serris A; Rautemaa-Richardson R; Laranjinha J; Candoni A; Garcia-Vidal C; Alastruey-Izquierdo A; Hammarström H; Seidel D; Styczynski J; Sabino R; Lamoth F; Prattes J; Warris A; Porcher R; Lanternier F;
    Clin Infect Dis; 2024 Jul; ():. PubMed ID: 39076104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies.
    Fernández-Ruiz M; Gioia F; Bodro M; Gutiérrez Martín I; Sabé N; Rodriguez-Álvarez R; Corbella L; López-Viñau T; Valerio M; Illaro A; Salto-Alejandre S; Cordero E; Arnaiz de Las Revillas F; Fariñas MC; Muñoz P; Vidal E; Carratalà J; Goikoetxea J; Ramos-Martínez A; Moreno A; Martín-Dávila P; Fortún J; Aguado JM;
    Transplantation; 2024 May; ():. PubMed ID: 38773846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring.
    Mikulska M; Melchio M; Signori A; Ullah N; Miletich F; Sepulcri C; Limongelli A; Giacobbe DR; Balletto E; Russo C; Magnasco L; Vena A; Di Grazia C; Raiola AM; Portunato F; Dentone C; Battaglini D; Ball L; Robba C; Angelucci E; Brunetti I; Bassetti M
    J Antimicrob Chemother; 2024 Apr; 79(4):835-845. PubMed ID: 38366368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study.
    Stull K; Esterberg E; Ajmera M; Candrilli S; Kitt TM; Spalding JR; Patel VP
    Infect Dis Ther; 2019 Dec; 8(4):641-655. PubMed ID: 31598932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole.
    Risum M; Vestergaard MB; Weinreich UM; Helleberg M; Vissing NH; Jørgensen R
    Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33922419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
    Monzó-Gallo P; Lopera C; Badía-Tejero AM; Machado M; García-Rodríguez J; Vidal-Cortés P; Merino E; Calderón J; Fortún J; Palacios-Baena ZR; Pemán J; Sanchis JR; Aguilar-Guisado M; Gudiol C; Ramos JC; Sánchez-Romero I; Martin-Davila P; López-Cortés LE; Salavert M; Ruiz-Camps I; Chumbita M; Aiello TF; Peyrony O; Puerta-Alcalde P; Soriano A; Marco F; Garcia-Vidal C
    Int J Infect Dis; 2024 Sep; 146():107188. PubMed ID: 39067149
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of unresolved skin lesion in a cobbler.
    Mert A; Kaya A; Yildiz Kaya S
    Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):329-330. PubMed ID: 38839162
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
    Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.